NDC 50090-0481-07 - Naproxen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0481
- Requested NDC
- 50090-0481-07
- Package NDCs from labels
- 50090-0481-0, 50090-0481-7, 50090-0481-4, 50090-0481-5, 50090-0481-1, 50090-0481-9, 50090-0481-2, 50090-0481-6, 50090-0481-07
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-01-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen - A-S Medication Solutions | A-S Medication Solutions | 2026-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0481-0 | Naproxen | 15 in 1 BOTTLE | TABLET | 15 | 31 | |
| 50090-0481-1 | Naproxen | 20 in 1 BOTTLE | TABLET | 20 | 31 | |
| 50090-0481-2 | Naproxen | 30 in 1 BOTTLE | TABLET | 30 | 31 | |
| 50090-0481-4 | Naproxen | 14 in 1 BOTTLE | TABLET | 14 | 31 | |
| 50090-0481-5 | Naproxen | 40 in 1 BOTTLE | TABLET | 40 | 31 | |
| 50090-0481-6 | Naproxen | 100 in 1 BOTTLE | TABLET | 100 | 31 | |
| 50090-0481-7 | Naproxen | 60 in 1 BOTTLE | TABLET | 60 | 31 | |
| 50090-0481-9 | Naproxen | 6 in 1 BOTTLE | TABLET | 6 | 31 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0481 | NAPROXEN TABLET [A-S MEDICATION SOLUTIONS] | 29 | Current NDC, Legacy NDC, 8 package rows | 20240905_000155a8-709c-44e5-a75f-cd890f3a7caf.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0481-0 | EA - Each | 50090-0481 | b73d0457-aa5d-44d1-9ffe-8e84bc4b53d5 | 1 | 2018-09-05 |
| 50090-0481-1 | EA - Each | 50090-0481 | 8d86527d-2599-4a30-82a6-c2dbd1b98722 | 1 | 2018-09-05 |
| 50090-0481-2 | EA - Each | 50090-0481 | d92301e9-5ae9-43b2-b86b-e58dad9eaea9 | 1 | 2018-09-05 |
| 50090-0481-4 | EA - Each | 50090-0481 | 1442acf3-7793-4a96-8ebf-f200f2e60bce | 1 | 2018-09-05 |
| 50090-0481-5 | EA - Each | 50090-0481 | bac00d6f-6aa6-473b-a517-2d181646cda1 | 1 | 2018-09-05 |
| 50090-0481-6 | EA - Each | 50090-0481 | 3c8620e3-6f7e-46f4-a0de-5ad10fba1c21 | 1 | 2018-09-05 |
| 50090-0481-7 | EA - Each | 50090-0481 | 33b2100d-a17f-4f6d-bad0-120a73bada72 | 1 | 2018-09-05 |
| 50090-0481-9 | EA - Each | 50090-0481 | 08fbf0d0-348d-48a8-b1a1-760f87e60643 | 1 | 2018-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | 24d44eb6-921e-4150-a6b2-81f42ced32ab | 2026-08-03 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| Good Sense Naproxen Sodium | NAPROXEN SODIUM | Preferred Pharmaceuticals Inc. | 2183df53-ac90-4d43-8a5d-8421036bc4cb | 2026-07-28 | Warnings | 9TN87S3A3C |
| Naproxen | NAPROXEN | Preferred Pharmaceuticals Inc. | 49a00870-f580-4eb9-a95d-48fa956f147f | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| Naproxen | NAPROXEN | Preferred Pharmaceuticals, Inc. | 9f026fd5-f996-4383-b528-841d38d3dab5 | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | 198012 57Y76R9ATQ |
| Naproxen | NAPROXEN SODIUM | Preferred Pharmaceuticals, Inc. | 20eb9d9f-11df-464f-a1b0-949f8fda4042 | 2026-07-28 | Warnings | 9TN87S3A3C |
| Naproxen | NAPROXEN | Preferred Pharmaceuticals Inc. | c5e52ddd-a909-487a-bb46-01ad35690665 | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| Naproxen Sodium | NAPROXEN SODIUM | PD-Rx Pharmaceuticals, Inc. | d2b1eedb-2be0-42af-ba0b-9da98560c91e | 2026-07-24 | Warnings | 9TN87S3A3C |
| Naproxen and esomeprazole magnesium | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | Preferred Pharmaceuticals Inc. | 65b892f2-8385-4bb0-8121-a58b01e8d13d | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Calamine | CALAMINE AND ZINC OXIDE | Marie's Original Formulas LLC | 57110309-9a3d-025f-e063-6394a90a015a | 2026-07-22 | Warnings | 1K09F3G675 |
| GOOD NEIGHBOR PHARMACY ARTIFICAL TEARS LUBRICANT EYE DROPS | POLYVINYL ALCOHOL, POVIDONE | AmerisourceBergen | ce6852a8-c5e6-403d-a7b4-a2e85d1ebb1f | 2026-07-22 | Warnings | FZ989GH94E |
| Calamine | CALAMINE AND ZINC OXIDE | Marie's Original Formulas LLC | 571083ce-cd35-a638-e063-6394a90ae4c7 | 2026-07-20 | Warnings | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Better Living Brands, LLC | c7ef0ef3-6861-4b94-af4b-371fee8c1f3d | 2026-07-16 | Warnings, Adverse reactions | 1K09F3G675 |
| Back and Muscle Pain | NAPROXEN SODIUM | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 4039504c-e612-4503-854a-62ee06780956 | 2026-07-13 | Warnings | 9TN87S3A3C |
| naproxen sodium | NAPROXEN SODIUM | H E B | b5dcf3df-2628-49c7-9d96-64886bebe631 | 2026-07-13 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | c28c4fd2-1428-421c-b62f-265e472d833e | 2026-07-09 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | ScieGen Pharmaceuticals, Inc. | 79f48c92-783d-40f2-9865-89958a9f9de6 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | 849431 849398 9TN87S3A3C |
| naproxen sodium pm | DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM | Meijer Distribution Inc | 34d635f8-9703-4c29-92a5-85d3b47c4c93 | 2026-07-07 | Warnings | 9TN87S3A3C |
| Aleve Caplets | NAPROXEN SODIUM | Select Consumer Group | 3ca84972-f8c9-1881-e063-6294a90a9070 | 2026-07-03 | Warnings | 9TN87S3A3C |
| Naproxen and esomeprazole magnesium | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | Proficient Rx LP | cfd4ef00-cfc4-4794-99fe-faa45eb2f617 | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Target Corporation | 36602b7a-99c0-f6a4-e063-6294a90a8758 | 2026-06-29 | Warnings | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.